Butyrolactone I blocks the transition of acute kidney injury to chronic kidney disease in mice by targeting JAK1.
Zhang Z, Zhao Z, Qi C, Zhang X, Xiao Y, Chen C, Zou Y, Chen X, Gu L, Huang J, Huang K, Xiang M, Zhang T, Tong Q, Zhang Y.
Zhang Z, et al. Among authors: zhao z.
MedComm (2020). 2025 Jan 21;6(2):e70064. doi: 10.1002/mco2.70064. eCollection 2025 Feb.
MedComm (2020). 2025.
PMID: 39845897
Free PMC article.